MetLife RIS — Direct and Allocated Expenses decreased by 24.4% to $93.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 9.4%, from $85.00M to $93.00M. Over 3 years (FY 2022 to FY 2025), RIS — Direct and Allocated Expenses shows an upward trend with a 12.0% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Lower expenses relative to revenue indicate improved operational efficiency and better cost management.
This captures the operating expenses, including administrative, personnel, and overhead costs, directly incurred by or a...
Comparable to operating expenses or SG&A allocated to business segments by large insurers.
met_segment_ris_direct_and_allocated_expenses| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $65.00M | $65.00M | $65.00M | $65.00M | $68.75M | $68.75M | $68.75M | $68.75M | $80.00M | $74.00M | $75.00M | $80.00M | $85.00M | $80.00M | $77.00M | $123.00M | $93.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +5.8% | +0.0% | +0.0% | +0.0% | +16.4% | -7.5% | +1.4% | +6.7% | +6.3% | -5.9% | -3.8% | +59.7% | -24.4% |
| YoY Change | — | — | — | — | +5.8% | +5.8% | +5.8% | +5.8% | +16.4% | +7.6% | +9.1% | +16.4% | +6.3% | +8.1% | +2.7% | +53.8% | +9.4% |